drug
(dexamethasone + tobramycin)
Marketedupdated 5mo agoby $HROW HARROW, INC.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 19, 2027
~1.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Aug 3, 2028formulationUS 77953161.8y
- Dec 19, 2027formulationUS 81015821.2y
- Dec 19, 2027formulationUS 84502871.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that